Algert Global LLC Organogenesis Holdings Inc. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.34 - $4.43 $24,991 - $47,312	-10,680 Reduced 44.12%	13,525 $43,000
Q2 2023 Aug 14, 2023	BUY	$1.9 - $4.3 $45,989 - $104,081	24,205 New	24,205 $80,000
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $142,863 - $245,641	-30,140 Reduced 59.82%	20,246 $99,000
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $325,997 - $482,194	50,386 New	50,386 $384,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.